Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × enzastaurin × Clear all

NCT00042666 2020-08-10

A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

Phase 2 Completed

55 enrolled 13 charts

Lymphoma, Non-Hodgkin